The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

Tier I

Sector: #18291

Sealed Hiding Place Room

Resource Cache

Resource Cache

Tier I

Requires 25% Tier Progress to Claim
Meme Cache

Meme Cache

Tier I

Requires 50% Tier Progress to Claim
Equipment Cache

Equipment Cache

Tier I

Requires 75% Tier Progress to Claim

After collecting, hiding places will be stored in your inventory and can be opened with Keys.

Other news

Wall Street Banks Bullish on SPCX Stock

Two major Wall Street banks, Mizuho and Morgan Stanley, have expressed a bullish outlook on SpaceX stock (SPCX), with price targets of $200 and $300 respectively.

user avatarMaya Lundqvist

Elon Musk Optimistic About SpaceX AI Developments

Elon Musk expresses optimism about SpaceX's AI developments, expecting significant advancements in the coming months.

user avatarKaterina Papadopoulou

MEXC Introduces MEXC CLI for Enhanced AI Trading Experience

MEXC introduces MEXC CLI, a command-line tool that allows users to connect their AI agents directly to the trading platform for seamless trading execution.

user avatarLeo van der Veen

XRP Reaches New All-Time High After SEC Settlement

XRP has surged to a new all-time high of 365 in July 2025 following a settlement in the SEC vs Ripple lawsuit.

user avatarAisha Farooq

Warren Buffett's Berkshire Hathaway to Earn $848 Million from Coca-Cola Dividends

Warren Buffett's Berkshire Hathaway is set to earn $848 million in dividends from Coca-Cola due to its long-term investment since 1994.

user avatarTenzin Dorje

Coca-Cola to Pay Quarterly Dividends on October 1, 2026

Coca-Cola announces a quarterly dividend of $0.53 per share to investors before the ex-dividend date of September 15, 2026, payable on October 1, 2026.

user avatarLi Weicheng

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.